Socioeconomic status and polycystic ovary syndrome by Merkin, Sharon Stein et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
Population and Quantitative Health Sciences 
Publications Population and Quantitative Health Sciences 
2011-03-15 
Socioeconomic status and polycystic ovary syndrome 
Sharon Stein Merkin 
Columbia College of Physicians and Surgeons 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/qhs_pp 
 Part of the Biostatistics Commons, Epidemiology Commons, Female Urogenital Diseases and 
Pregnancy Complications Commons, and the Health Services Research Commons 
Repository Citation 
Merkin SS, Azziz R, Seeman TE, Calderon-Margalit R, Daviglus ML, Kiefe CI, Matthews KA, Sternfeld B, 
Siscovick DS. (2011). Socioeconomic status and polycystic ovary syndrome. Population and Quantitative 
Health Sciences Publications. https://doi.org/10.1089/jwh.2010.2303. Retrieved from 
https://escholarship.umassmed.edu/qhs_pp/987 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Population and 
Quantitative Health Sciences Publications by an authorized administrator of eScholarship@UMMS. For more 
information, please contact Lisa.Palmer@umassmed.edu. 
Socioeconomic Status and Polycystic Ovary Syndrome
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Ronit Calderon-Margalit, M.D., M.P.H.,3 Martha Daviglus, M.D., Ph.D.,4 Catarina Kiefe, Ph.D., M.D.,5
Karen Matthews, Ph.D.,6 Barbara Sternfeld, Ph.D.,7 and David Siscovick, M.D., M.P.H.8
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common metabolic-endocrine disorder in women and is
associated with a number of metabolic morbidities. We examined the association of PCOS and its components
with socioeconomic status (SES) over the life course to explore the role of the environment on the development of
PCOS.
Methods: Participants included 1163 women, aged 34–39, from the Coronary Artery Risk Development in Young
Adults (CARDIA) Women’s Study, examined at year 16 of the CARDIA study (2001). PCOS was defined
according to the 1990 National Institutes of Health (NIH) criteria.
Results: Logistic regression models, adjusted for age, body mass index (BMI), waist circumference, and oral
contraceptive (OC) use, demonstrated a statistically significant association between those women with low
parental education=high personal education and PCOS (odds ratio [OR] 2.5, 95% confidence interval [CI] 1.4-
4.4).
Conclusions: Our results indicate that women who experienced low childhood SES are at increased risk of
PCOS, but this risk is limited to those who have personally attained a high level of education. More research is
needed to determine the childhood socioeconomic factors that might influence this risk and whether conditions
associated with upward life mobility play a role or if this group of at-risk women is simply more likely to recall
the symptoms that define PCOS.
Introduction
Polycystic ovary syndrome (PCOS) is one of the mostcommon endocrine disorders in women, with an esti-
mated prevalence of nearly 7%–10%.1–3 This syndrome is
characterized by ovulatory dysfunction, hyperandrogenism,
and polycystic ovaries.4 Despite a relatively high prevalence,
the etiology and natural history of PCOS are not well un-
derstood; current theories suggest that increased risk of PCOS
may involve a combination of genetic susceptibility and a
myriad of environmental factors, including diet, lifestyle, and
social factors.5,6 The importance of gaining a greater under-
standing of this relatively common syndrome is further un-
derscored by growing evidence that PCOS is strongly
associated with several metabolic conditions, including in-
sulin resistance,7 type 2 diabetes mellitus, hypertension and
dyslipidemia,8 the metabolic syndrome,9 and cardiovascular
outcomes.10
The association of PCOS and its components with socio-
economic status (SES) might shed light on the role of the en-
vironment in the development of this condition. Research has
shown that individuals with lower SES are more at risk for
engaging in adverse health behaviors, including smoking, lack
of physical activity, and poor nutritional diet11,12; among wo-
men, obesity is associated with low SES.13,14 Studies have also
shown that smoking and obesity can exacerbate insulin resis-
tance,15 which is a condition highly correlated with and part of
the pathogenesis of PCOS.16 Moreover, there is clear evidence
of an association between low SES and cardiovascular disease
(CVD),17–20 as well as the metabolic syndrome and its various
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components.21 Considering that PCOS symptoms often begin
in adolescence, we chose to examine the association between
SES over the life course, from childhood to adulthood.
The objectives of this study are to (1) examine the associa-
tion between SES and the prevalence of PCOS to determine if
exposure to low SES over the life course is associated with an
increased prevalence of PCOS; as part of this objective, we
propose to examine how the different components of PCOS
relate to SES, and (2) examine a possible interaction of this
SES-PCOS association with race.
Materials and Methods
Study population
The study population included participants in the Coronary
Artery Risk Development in Young Adults (CARDIA) Wo-
men’s Study. CARDIA is a prospective, multicenter, popula-
tion-based study of coronary artery disease (CAD) risk factors
in young adults. This study population included 5115 men and
women aged 18–30 at baseline, recruited in 1985–1986 from
four metropolitan areas, including Birmingham, Alabama,
Chicago, Illinois, Minneapolis, Minnesota, and Oakland, Cali-
fornia, using community-based or list-based sampling frames.
Follow-up examinations were conducted 2, 5, 7, 10, 15, and 20
years after baseline, with retention rates of 91%, 88%, 81%, 79%,
74%, and 72%, respectively. Details of the study design have
been published.22 At the year 15 examination, CARDIA wo-
men were recruited to participate in an ancillary study at year
16 (2002–2003), the CARDIA Women’s Study (CWS), designed
to examine the associations among androgens, polycystic
ovaries, and cardiovascular risk. To be eligible for CWS, wo-
men had to have attended the year 15 examination have at least
one ovary, and not be pregnant. A total of 1163 women (86% of
the eligible sample) completed the CWS examination. Our
study sample consisted of 545 white and 618 black women,
aged 34–49, who participated in the CWS.
Measures
Ovulatory dysfunction was based on self-reported infor-
mation obtained from the CWS questionnaire, where the
participants were asked a variety of questions about the reg-
ularity of their menstrual cycles (excluding when they were
pregnant, nursing, or experiencing menopause or surgery)
when they were aged 20–30, as well as in the past year
(number of days between menstrual cycles were classified as
Less than 20, 20–35, 26–33, 34–45, More than 45). Additional
information was obtained regarding oral contraceptive (OC)
use and reasons for use.
Information on hirsutism included self-reported information
on unwanted hair growth (not including lower leg or under-
arm) recalled from ages 20–30 and in the past year (yes or no).
Testosterone (T) was measured using stored sera from the
CARDIA year 2 follow-up examination (to correspond to the
20–30 age range) and sera collected at the CWS (year 16)
examination. Total T was measured using a competitive
immunoassay (Bayer Diagnostics) that employs direct chemi-
luminescent technology on the 180 Automated Chemilumi-
nescent System (ACS) Free T was calculated based on total
T and sex hormone-binding globulin (SHBG) measures.23 Total
and free T cutoffs of 80 and 0.65, respectively, were based on
the 95th percentile T values for the nonhirsute, non-
oligomenorrheic study population. T values were not consid-
ered for women using OC.
Life course SES included measures of parental education to
indicate childhood SES and respondents’ personal education to
indicate adult SES. Although education is the only indicator
used as a proxy for SES in this study, it is a common measure
that has been well established in its inverse relationship with
health and considered by some to be the best measure of SES
with regard to health.24 Parental education was assessed at
baseline, based on participants’ reports of the highest level of
education obtained by their parents or primary caregiver.
Personal education levels were measured in terms of the
highest education degree earned as of year 15 (i.e., when par-
ticipants were aged 32–47 years and not likely to change edu-
cation levels). Both parental and personal education levels were
classified ashigh school and>high school education. Income
was not considered in this analysis, as it was only available
starting at year 5 and no parental income information was
available.
To consider a life course trajectory of SES, we created four
categories reflecting the possible combinations of parental
and personal education, including low parental=low per-
sonal education, low parental=high personal education, high
parental=low personal education, and high parental=high
personal education.
Age and race were reported at baseline. Body mass index
(BMI) and waist circumference were obtained from the year 2
examination (second follow-up visit) to correspond as much
as possible to when participants were aged 20–30. BMI levels
were classified as underweight (<18.5), normal (18.5–24.0),
overweight (25.0–29.0), and obese (30). High waist circum-
ference was based on National Cholesterol Education Pro-
gram (NCEP) criteria and classified as >88 cm.25
Defining PCOS
The definition of PCOS was based on the National In-
stitutes of Health (NIH) criteria suggested at an expert con-
ference in 1990, considering the presence of ovulatory
dysfunction plus clinical or biochemical signs of hyperan-
drogenism after exclusion of related disorders.26 We defined
ovulatory dysfunction as34 or<20 days between menstrual
cycles or using OC to regulate periods as recalled from when
participants were aged 20–30. Hyperandrogenism was de-
termined based on hirsutism (self-reported unwanted hair
growth at ages 20–30) or high T, defined by either high free T
(>0.65 ng=dL, >0.02 nmol=L) or high total T (>80 ng=dL,
>2.78 nmol=L) measured at year 2 for those not taking OC.
Participants were also asked about experiences during the
CWS year. We expanded the PCOS definition to include in-
formation on the PCOS components as recalled from the past
year, but only for women aged <40 who had no PCOS based
on recall information from ages 20–30; for these same women,
current OC use to regulate periods=vaginal bleeding was
considered a marker of ovulatory dysfunction. When con-
sidering PCOS status, we included only participants who had
at least some information on both ovulatory dysfunction and
hyperandrogenism (n¼ 938).
In sensitivity analyses, we considered an additional mea-
sure of PCOS that defined ovulatory dysfunction more re-
strictively, as >45 days between menstrual cycles (PCOS 2).
A description of this measure can be found in Table 4. In
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additional analyses, we considered the set of criteria estab-
lished at a consensus workshop in Rotterdam in 20034 that
included the presence of polycystic ovaries. However, be-
cause 40% of the sample did not receive a full transvaginal
ultrasound examination, we do not include those results.
Although the NIH definition of PCOS calls for the exclusion
of related disorders, we should note that the prevalence of
thyroid dysfunction, hyperprolactinemia, congenital adrenal
hyperplasia, or androgen-secreting tumors is relatively rare in
patients with suspected androgen excess or PCOS,3 allowing
us to disregard these disorders in our analysis. In our study
sample, we had information available only about self-
reported thyroid problems, indicated by 46 women in our
study sample. In sensitivity analyses, we reran the models
and excluded those participants and found the same results;
we thus present the main results disregarding this condition.
Statistical analyses
Initial descriptive analyses were conducted to compare the
study sample with the eligible CWS sample, based on year 15
attendance. We then assessed prevalence of PCOS and its
components, by age, race, SES, obesity, and high waist cir-
cumference; p values for differences were obtained using
t tests for continuous variables and chi-square tests for cate-
gorical measures. Logistic regression models were used for
multivariate analyses, and models were fit for PCOS and each
component. Interactions between race and each education
level, as well as race and the combined life course education
levels, were assessed using interaction terms. In addition,
models were stratified by race groups; p values <0.05 were
considered statistically significant. SAS version 9.2 was used
for these analyses.
Results
Compared to nonparticipants from the CARDIA popula-
tion who had attended the year 15 follow-up examination, our
CWS study sample had a slightly higher percentage of black
participants, women with less education, and women with
higher BMI. The remaining examined characteristics were not
significantly different between the groups (data not shown).
The prevalence of PCOS was 10.7%. When considering the
individual components separately, 29.0% of the sample re-
ported oligomenorrhea, 23.3% reported hirsutism, and 10.3%
had high T levels (Table 1). The prevalence of PCOS and its
components varied by parental and personal education levels.
For all outcomes, prevalence was higher at the lower parental
education level, although this association was not statistically
significant for hirsutism. The association was less consistent
for personal education, with a significantly higher prevalence
of PCOS at the highest education level and greater prevalence
of high T associated with lower education.
The only statistically significant racial difference was
higher prevalence of high T among blacks compared to
whites. Obese participants and those with high waist cir-
cumference had a significantly higher prevalence of high T;
obese participant also had a higher prevalence of hirsutism.
Although not shown in Table 1, younger age at reporting
(34–39 at the CWS examination) was associated with a higher
prevalence of PCOS, oligomenorrhea, and hirsutism. This
association was expected, as recall is likely better in the
younger age groups for whom the request for information
about their 20s reflects recall over a shorter period of time. We
did not include these results in Table 1 because age is also built
into the definition, where information about symptoms at
year 16 was only incorporated into the definition for those
<40 years.
When considering both parental educational and personal
education in the same model and adjusting for age at the CWS
examination, race, BMI at year 2, waist circumference at year
2, and OC use at years 2 and 16, the results were different by
type of education indicator (results not shown). Low parental
education was associated with higher risk of PCOS and most
of its components, whereas low personal education was as-
sociated with lower risk of these conditions (for PCOS, odds
ratio [OR] 2.2, 95% confidence interval [CI] 1.2-3.9 for low
parental education; OR 0.4, 95% CI 0.2-0.7 for low personal
education). On further examination of the joint effects of pa-
rental and personal education, the results indicated that the
greatest risk of PCOS and its components was associated with
those with low parental high personal education compared to
high parental=high personal education. As shown in Table 2,
the models yielded statistically significant ORs for this group
for PCOS (OR 2.5, 95% CI 1.4-4.4) and for hirsutism (OR 1.6,
95% CI 1.1-2.4). ORs indicated risk for oligomenorrhea and
high T (borderline significance). For those who were down-
wardly mobile (i.e., with high parental education coupled
with low personal education), there was an apparent protec-
tive effect associated with PCOS, although it was not statis-
tically significant. For those with low parental=low personal
education, the only statistically significant association found
was a strong risk associated with high T levels (OR 2.3, 95% CI
1.2-4.6). Interaction terms for race and education levels were
not statistically significant.
Considering the evidence that obese women with PCOS are
more insulin resistant than lean women with PCOS,27,28
possibly indicating that this phenotype may be more sus-
ceptible to environmental factors, we assessed how these SES
associations might interact with obesity. We reran the model
in Table 2 for PCOS, stratified by obesity at year 2 (Table 3).
Similar to the nonstratified findings, the only statistically
significant risk of PCOS was associated with low paren-
tal=high personal education, although this risk was consid-
erably stronger among obese compared to nonobese women
(OR 4.4, 95%CI 1.0-18.4 for obese and OR 2.0, 95% CI 1.1-3.9
for nonobese women).
When considering an alternate, more restrictive measure of
PCOS, the results were similar, with a higher OR of PCOS for
those with low parental=high personal education among ob-
ese women (OR 5.9, 95% CI 1.1-31.7) (Table 4). In additional
sensitivity analyses, we considered finer categories of SES;
however, the results yielded the same trends, and, thus, to
ensure adequate power, we present the main findings.
Discussion
Our results indicate a strong association between low
childhood SES and PCOS, primarily among women with high
SES in adulthood. After adjusting for age, race, BMI, waist
circumference, and OC use, this group was over twice as
likely to have PCOS as women with both high parental and
high personal education. We further found that this associa-
tion was strongest among obese women, with >4 times
the risk associated with PCOS for obese women with low
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parental=high personal education. Women with low paren-
tal=low personal education, as well as those with high pa-
rental=low personal education did not show an increased risk
of PCOS. There was no statistically significant interaction
between race and SES with regard to PCOS.
Although other studies have not explored the association
between PCOS and SES, there is abundant evidence that
among women, low SES is associated with many conditions
related to PCOS, including obesity29 and insulin resistance.30
Low childhood SES, in particular, has been found associated
with related conditions, including diabetes,31 insulin resis-
tance,30,32 obesity,29 and coronary heart disease (CHD).32–34
Moreover, as in our analysis, these studies found that the
association between these conditions and low childhood SES
persisted even among those who moved up into higher levels
of SES during adulthood.30,33,34 The mediating factors that
might link low childhood SES to a higher risk of developing
PCOS include poor intrauterine or childhood nutrition,32 ex-
cessive weight gain in infancy or early childhood,31,35,36 and
adopting adverse health behaviors.11 Research suggests that
these factors might influence later metabolic dysfunc-
tion,31,35,36 and there is growing evidence that prenatal an-
drogen excess plays a role in the development of PCOS.37 A
measure of childhood SES might thus be more influential than
personal education or other measures of SES that are attained
later in life, when PCOS may already have developed.
Although other childhood factors were not available in this
dataset, we explored some of the potential adverse health
behaviors that may have influenced the development of
PCOS, including diet (total caloric intake, fat and carbohy-
drate intake), weight change, smoking, and physical activity,
as measured at the CARDIA year 2 follow-up (data not
shown). Although adjusting for these factors did not change
the relationship between low SES and PCOS, it is possible that
these measures did not adequately reflect prepubescent ex-
posures that would most influence the development of PCOS.
In these analyses, we found that the low childhood SES-
PCOS association was most pronounced among obese wo-
men. Several studies have shown that obesity exacerbates
insulin resistance and hyperandrogenism, and there is evi-
dence suggesting that obese women with PCOS are more
insulin resistant then their lean counterparts.28,38 Our findings
Table 1. Prevalence of Polycystic Ovary Syndrome and Individual Components by Select Characteristics
PCOSa Oligomenorrheab Hirsutismc High testosteroned
n¼ 938 n¼ 939 n¼ 1157 n¼ 800
Overall, % 10.7 29.0 23.3 10.3
Race, % n¼ 938 n¼ 939 n¼ 1157 n¼ 800
White 10.7 27.7 24.1 7.3
Black 10.6 30.2 22.5 12.6
p value 0.9 0.4 0.5 0.02
Parental education (baseline), % n¼ 889 n¼ 890 n¼ 1093 n¼ 751
High school 13.7 32.7 25.1 14.2
>High school 9.0 26.5 23.3 8.4
p value 0.03 0.05 0.5 0.01
Education (year 15), % n¼ 886 n¼ 887 n¼ 1087 n¼ 748
High school 8.1 29.4 20.2 12.5
>High school 12.1 28.3 25.1 8.1
p value 0.05 0.7 0.06 0.05
BMI (year 2),% n¼ 900 n¼ 901 n¼ 1111 n¼ 785
Underweight (<18.5) 11.3 25.7 27.3 0
Normal (18.5–24) 9.5 29.4 20.4 7.8
Overweight (25–29) 10.6 27.8 24.7 13.7
Obese (30) 14.4 31.0 28.5 14.3
p value 0.4 0.9 0.08 0.01
Obesity (year 2),% n¼ 900 n¼ 901 n¼ 1111 n¼ 785
Obese (BMI30) 14.4 31.0 28.5 14.3
Nonobese (<30) 9.9 28.8 21.9 9.1
p value 0.09 0.6 0.04 0.04
High waist circumference (year 2), (%) n¼ 897 n¼ 898 n¼ 1107 n¼ 781
>88 cm 15.4 32.2 25.8 18.1
88 cm 9.7 28.5 22.5 8.5
p value 0.04 0.4 0.3 0.0006
aPCOS: Defined as irregular menses (34 or <20 days between cycles) or taking oral contraceptive (OC) pills to regulate periods) during
ages 20–30 and either unwanted hair growth (during their 20–30s) or high free (0.65) or total testosterone (T) (>80) measured at year 2 for
those not on OC. These measures were also considered for the past year (year 16) for those aged <40 who had no PCOS based on recall
information from ages 20–30; for these same women, current OC use (year 16) to regulate periods=vaginal bleeding was considered a marker
of oligomenorrhea.
bOligomenorrhea: Defined as 34 or <20 days between cycles or taking OC pills to regulate periods during ages 20–30 or 34 or <20 days
between cycles in past year if <40 years old and no menopause or hysterectomy) for women <40 years of age. Current OC pill use (year 16) to
regulate periods=vaginal bleeding was also considered a marker of oligomenorrhea.
cHirsutism: Self-reported unwanted hair growth at ages 20–30 or in past year (only for women <40 years).
dHigh testosterone: Total T>80 or free T>0.65 at year 2 or year 16 (restricted to those not on OC pills during those years and to those aged
<40 for year 16 values).
BMI, body mass index; PCOS, polycystic ovary syndrome.
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highlight the important role that lifestyle factors and envi-
ronmental conditions may play in the development of PCOS,
particularly in the development of the PCOS phenotype most
vulnerable to negative metabolic sequelae, as we described
earlier. This is also consistent with epigenetic studies that
have suggested that genetic predisposition for PCOS can be
influenced by environmental factors,39,40 including diet and
exercise. Our findings with regard to obesity could indicate
that the principal driver of low parental education on PCOS is
through development of poor nutritional habits and the
subsequent development of obesity.
It is less clear why the low childhood SES-PCOS association
might be limited to those who attain a higher level of educa-
tion. We speculate that this may be the result of how PCOS
was determined in this study. Aside from measuring T levels,
PCOS was primarily determined based on self-reported in-
formation about menstrual cycles, hair growth, and OC use. It
is possible that those with higher education were more likely
to recall and report past and current health conditions and
that those women might be more likely to use the healthcare
system and, thus, have a diagnosis. Moreover, women with
higher education may be more likely to complain of hirsutism
or use OC to regulate menstrual cycles. Consequently, the
group with the most risk associated with poorer childhood
conditions and more ability to recall because of higher at-
tained education might indeed be at greater risk of being as-
signed as having PCOS in this study. This might also explain
the protective (although not statistically significant) effect for
those with high parental education=low personal education,
that is, a combination of better childhood socioeconomic
conditions and perhaps less likelihood of recalling these
health measures. This hypothesis is supported by the fact that
the one measure that did not show this effect was high T, a
measure that did not require recall information. Those with
low parental=low personal education had, as expected, the
highest association with T, whereas the risk was reduced (and
borderline significant) for those with low parental=high per-
sonal education, and further reduced and not significant for
those with high parental=low personal education (Table 2).
Those results show that low parental education is clearly a
more influential factor in its association with high T, although
low personal education confers some risk as well.
Notwithstanding these concerns with the self-reported el-
ements of our PCOS measure, our results suggest an addi-
tional hypothesis that might explain why the risk of PCOS
associated with low parental education is limited to women
with higher education. It is possible that women who achieve
a higher level of education distinct from their parents (i.e.,
upwardly mobile) suffer more from peripubertal stress, a
greater incidence of obesity, and thus early (and perhaps
persistent) disruption in their menstrual cyclicity.41 Although
no other study has examined the effects of upward socio-
economic mobility and PCOS, some studies have found up-
ward mobility to be associated with persistent risk of CVD
and mortality despite its overall advantage compared to
downward socioeconomic mobility.42,43 This hypothesis
warrants further research.
The present study has a number of strengths, including the
use of a diverse, young, population-based sample, but there
are some limitations. The outcome measure we used to
identify PCOS was primarily determined via self-reported
menstrual irregularities, OC use, and excessive hair growth.
Table 2. Odds Ratios and 95% Confidence Intervals for Life Course Socioeconomic Status Trajectory
with Risk of Polycystic Ovary Syndrome and Related Components
Joint parental and personal education categories
Low parental=low
personal education
Low parental=high
personal education
High parental=low
personal education
High parental=high
personal education
n n¼ 161 n¼ 133 n¼ 138 n¼ 362
PCOSa 794 0.9 (0.5-1.8)b 2.5 (1.4-4.4) 0.6 (0.3-1.4) 1.0
n¼ 162 n¼ 133 n¼ 138 n¼ 362
Oligomenorrheaa 795 1.3 (0.9-2.0) 1.4 (0.9-2.2) 1.0 (0.6-1.5) 1.0
n¼ 193 n¼ 173 n¼ 176 n¼ 428
Hirsutisma 970 0.7 (0.5-1.2) 1.6 (1.1-2.4) 0.9 (0.6-1.4) 1.0
n¼ 131 n¼ 109 n¼ 146 n¼ 291
High testosteronea 677 2.3 (1.2-4.6) 2.0 (0.9-4.2) 1.1 (0.5-2.4) 1.0
aFor definitions, see Table 1.
bOR (95% CI).
Models are additionally adjusted for age at year 16, BMI at year 2, waist circumference at year 2, race, OC use at year 2, and OC use at year 16.
OR, odds ratio; CI, confidence interval.
Table 3. Odds Ratios and 95% Confidence Intervals for Life Course Socioeconomic Status Trajectory
with Risk of Polycystic Ovary Syndrome, by Obesity at Year 2
PCOSa n
Low parental=low
personal education
Low parental=high
personal education
High parental=low
personal education
High parental=high
personal education
Obese 142 0.7 (0.1-3.3) 4.4 (1.0-18.4) 0.5 (0.1-2.3) 1.0
Nonobese 652 0.9 (0.4-2.0) 2.0 (1.1-3.9) 0.6 (0.2-1.6) 1.0
aFor definition, see Table 1.
Models are additionally adjusted for age at year 16, OC use at year 2, and OC use at year 16.
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Aside from the fact that the validity of recalled information
about menstrual cycle length and variability may be differ-
ential by SES, studies have also shown that self-reports may
be somewhat unreliable.44,45 An ideal analysis would include
recorded menstrual cycle length. Whereas clinical measures of
hirsutism would also be ideal, studies have found that even
among women with minimum excess hair growth, 50% were
diagnosed with PCOS,46 and, thus, self-reported hair growth
is likely an adequate indicator of hirsutism. Additional limi-
tations include missing values, with about 30% of the study
sample missing T measures, mostly because of concurrent OC
use. Although these women were able to contribute infor-
mation about the other PCOS components, further analysis
showed that they had a higher prevalence of oligomenorrhea
and low parental=high personal education than women not
missing T. The exclusion of these missing data potentially
dilutes our findings.
Conclusions
This study points to an association between low childhood
SES and PCOS, particularly among those who later achieve
high personal education and especially for obese women in
this category. Our findings suggest that future research is
warranted to explore early life exposures related to low SES
and possibly to upward mobility, including intrauterine and
postnatal nutrition and growth, and how they may influence
the development of PCOS. These studies should strive to in-
clude validated measures of PCOS symptoms to avoid any
self-reported bias that might be associated with social factors.
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